NEWS |
|
When newly diagnosed with diabetes, it’s natural to feel overwhelmed, scared, uncertain, and confused, asking yourself, “What will my life be like now?" You are not alone.
1.5 million Americans are diagnosed with diabetes every year.*
Insulin pump therapy provides more flexibility for your lifestyle while giving you greater control of your diabetes. The MiniMed™ 670G insulin pump system is revolutionary technology that mimics some of the functions of a healthy pancreas.
of MiniMed™ 670G users said that it met or exceeded their expectations about improving overall health.
Breakthrough diabetes technology that lets you focus more on living your life.
Continuous glucose monitoring (CGM) gives you a more complete picture of your glucose levels, which can lead to better lifestyle decisions and better glucose control.
Celebrity chef Sam Talbot shares how his Medtronic CGM makes life with type 1 simpler.
SugarIQ™ Diabetes Assistant app. Exclusively available with the Guardian™ Connect system.
Whether your child was just diagnosed with diabetes or has been managing it for some time, Medtronic is the right place to turn for help. Over 250,000 families with a family member with diabetes count on Medtronic and our diabetes products.
You have type 2 diabetes, but diabetes shouldn’t rule your life. You want to manage your sugar levels well, but with shots and oral medication, you must deal with frequent challenges to keep your sugar levels under control. You wish there was an easier way to manage insulin dosing without compromising your health. You’re not alone. Here you will find some useful information to help you learn more about Medtronic and treatment options.
Diabetes takes no breaks, neither do we. Your Medtronic family is always by your sideSM. Here are some quick links to pages you may be looking for.
Diabetes never rests, but you are not alone. We’re with you on this journey. We’ve supported over 1.2 million people living with diabetes around the world. From your first training session to ongoing support, our global team is always there to help.
Our unparalleled service is the # 1 reason people with diabetes stay with us.
* American Diabetes Association, statistics about diabetes.
# Refers to SmartGuard™ Auto Mode. Some user interaction required. Individual results may vary.
§ Customer training phase – data on file.
ß BG testing, proper mobile device, settings required. See bit.ly/GCRisks. Optional SugarIQ™app pictured.
‡ At the time of manufacture and when the reservoir and tubing are properly inserted, your pump is waterproof. It is protected against the effects of being underwater to a depth of up to 12 feet (3.6 meters) for up to 24 hours. This is classified as IPX8 rating. See user guide for more details. The sensor and transmitter are water-resistant at 8 feet (2.4 meters) for up to 30 minutes. CGM readings may not be transmitted from the CGM to the pump while in water.
† WARNING (For MiniMed™ 670G System Users Ages 7-13):
The low sensor glucose alert functionality is distinct from the automated insulin dosing function of the MiniMed™ 670G system. When used in Auto Mode, the MiniMed™ 670G system has been shown to be safe and effective for its intended use in this population. However, do not rely solely on the use of a low sensor glucose (SG) value for “Alert on Low” or “Alert before Low” for alerts set at 50 mg/dL and 60 mg/dL. A low sensor glucose alert may not reflect the user’s true blood glucose at these levels or may not alert. Do not ignore symptoms of low glucose. Always confirm your sensor glucose readings with your blood glucose meter and treat according to the recommendations of your healthcare professional. Solely relying on these sensor glucose alerts and readings for treatment decisions could result in missing severe hypoglycemia (low blood glucose) events.
1. Smart CGM predicts future high and low sensor glucose events up to 60 minutes in advance and provides access to additional algorithms and insights that can inform users of clinically relevant glucose patterns.
2. Hanas R, Adolfsson P, Elfvin-Akesson K et al. Indwelling catheters used from the onset of diabetes decrease injection pain and pre-injection anxiety. J Pediatr. 2002;140(3)315-320
3. Riley D, Raup G. Impact of a subcutaneous injection device on improving patient care. Nurs Manage. 2010;41(6):49-54
AT
AU
BE
BG
CA
CH
CN
CZ
DE
DK
ES
EU
FI
FR
GR
HU
IE
IN
IT
JP
NL
NO
PL
PT
RU
SE
UK
ZA
Alert: Product and Safety Notice
